Loading....
Saturday, October 24, 2026
9:30 AM EDT - 11:00 AM EDT
WEBINAR DESCRIPTION
During this webinar, Drs. Uma Borate and Alice Mims will discuss lower risk MDS, higher risk MDS and MDS/MPN overlap. They will explore key disease characteristics, current treatment approaches, and considerations for managing these complex myeloid neoplasms. After the presentation, there will be a Q & A session. Questions can be submitted in advance to [email protected].
Thank you to our 2026 Sponsors.
Diamond Level
Silver Level
Bronze Level
Edit this section of copy to tell your supporters how their action will help ignite change. Use stories, quotes, data, and other inspiring content to capture their attention and get them to act.
WEBINAR FACULTY
Uma Borate is a hematologist specializing in the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN) and clonal cytopenias of unknown significance.
Alice Mims is a medical oncologist and physician-scientist specializing in treating patients with acute leukemias, chronic myeloid leukemia, myelodysplastic syndromes and other myeloid cancers.
Thank you for registering for this webinar.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone.
If you do not receive the link, please check your Spam/Junk folders.
If you have not received a registration confirmation, please email [email protected]
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.